GlobeNewswire

InnovMetric releases PolyWorks® 2017, delivering a new control-centric reviewing workflow

Dela

QUEBEC, QC, Canada, May 09, 2017 (GLOBE NEWSWIRE) -- InnovMetric Software Inc., the leading provider of universal 3D metrology software solutions, launched PolyWorks 2017, the latest release of the company's universal 3D metrology software platform. PolyWorks 2017 delivers a new control-centric reviewing workflow - a key upgrade for all portable metrology and CNC CMM measurement specialists that need to share large metrology projects, containing hundreds of dimensional and GD&T controls, with colleagues, customers, and suppliers. It also provides a major technology upgrade for large-volume metrology applications, and a unique approach to real-time collision analysis for more efficient CNC CMM project setups.

Control-centric reviewing workflow

"Because they provide invaluable feedback on manufactured parts and on the performance of the manufacturing process, 3D measurements must be efficiently planned and executed by measurement specialists. Then, the results have to be thoroughly reviewed by manufacturing specialists to make informed engineering decisions. With 3D inspection projects designed for planning and executing measurements, time-consuming manipulations are required when sharing measurement results using standard 2D reports. For reviewers, interpreting results found in static tables and snapshots within extensive reports can be challenging, frustrating, and inefficient. Oftentimes, this traditional approach requires back-and-forth communication with measurement specialists to extract additional information from the 3D inspection project," said Marc Soucy, President of InnovMetric. "With the new dimensional-control-centric approach in PolyWorks 2017, the PolyWorks|Inspector(TM) 3D metrology project  is  the report! By enabling measurement specialists to communicate results directly in 3D, considerable productivity gains are guaranteed for our customers. PolyWorks 2017 also empowers reviewers to investigate measurement results contextually in 3D with dynamic navigation tools."

Using the new Control Reviewer in PolyWorks|Inspector(TM) or in the free PolyWorks|Viewer(TM), measurement specialists and manufacturing specialists can now:

  • Access a global list of dimensional controls sorted by characteristic index, making it the ideal tool to prepare first-article inspection reports.
  • Add custom controls to the global list of controls; for example, those measured using manual gauges.
  • Easily split an inspection project into small and logical groups of controls called Control Views.
  • Tie individual controls to specific data alignments and coordinate systems, enabling multicontextual Control Views.
  • Search, sort, and filter controls to highlight critical results.
  • Display control views automatically in 3D with the right point of view.
  • Generate formatted reports automatically.

Major technology upgrade for large-volume metrology applications

InnovMetric is proud to release its most significant technology enhancements for customers who need to assemble and inspect large structures such as those found in the aerospace, shipyard, and energy industries. Users can now:

  • Predefine and configure a list of laser tracker devices, and connect to multiple trackers simultaneously. With PolyWorks 2017, to guide assembly building in real time, switch the active tracker instantaneously and feed measured reflector positions to digital readouts.
  • Align point-to-object using a powerful technique that aligns points to different geometrical characteristics of matched objects (such as center points, axes, or surfaces) and control the alignment direction, weight, and participation to the scaling factor computation for each pair of matched geometries.
  • Probe surface features before their nominal components are defined or the part is aligned to the CAD model.

Real-time collision analysis for more efficient CNC CMM project setups

Measurement specialists who define probing and laser scanning paths on CNC CMMs now have access to a collision analysis engine that detects potential tool collisions with the part or the fixtures, and provides visual feedback on problematic tool paths in the Sequence Editor and the 3D Scene.

Thanks to two major innovations, the PolyWorks collision analysis approach stands out from competing CMM software products:

  • PolyWorks collision analysis is carried out in real time while the measurement sequence is created or edited, such as when new measurement objects are added to a sequence. This allows operators to immediately fix problematic tool paths and avoid accumulating issues.
  • PolyWorks collision analysis is performed both offline and online, and warns users about potential collisions even when they launch a measurement operation outside of the Sequence Editor. Traditionally, this feature is offered solely as an offline functionality in other software.

For more information about PolyWorks 2017, including products, demonstrations, and upcoming PolyWorks Conference events, please visit: www.innovmetric.com.

About InnovMetric Software

Founded in 1994 and headquartered in Quebec, QC, Canada, with subsidiaries worldwide, InnovMetric Software Inc. is the leading provider of universal 3D metrology software solutions. The world's largest industrial manufacturing organizations (Toyota, GM, Volkswagen, Honda, BMW, Daimler, Ford, Rolls-Royce, Pratt & Whitney, Boeing, Embraer, Bombardier, Apple, and many more) trust InnovMetric's PolyWorks® software solutions and associated technical services to maximize the benefits of 3D measurement technologies for their engineering and manufacturing applications.

With its subsidiaries and joint ventures, InnovMetric has more than 250 employees in 14 countries: Canada, United States, Mexico, Brazil, France, Italy, Spain, Netherlands, Sweden, Turkey, India, Thailand, China, and Japan.

Contact: Patrick Castera
Tel: 1-418-688-2061
Email: pcastera@innovmetric.com
Website: www.innovmetric.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: InnovMetric Software Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum